unknown
Stage
1
Investors
About
GILUPI GmbH develops medical devices and workflows to capture and analyze circulating tumor cells (CTCs) directly from patients' blood. Its flagship product is an in vivo capture device (a functionalized wire) used for cancer diagnostics and monitoring.
Explore GILUPI GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.